Fusions of anaplastic lymphoma kinase (ALK), and ROS proto-oncogene 1 receptor tyrosine kinase (ROS1), were predicted directly from the H&E-stained WSI of postoperative tissues of patients with NSCLC. The gene discussed is ALK; the disease is non-small cell lung carcinoma.